Key Points. CNS relapse rate in HGBCL-DH-BCL2 (6.8% at 2 years) is much lower than previously reported and is associated with clinical risk factors.DZsig r
Peripheral T-cell lymphomas are rare and have poorer prognoses than more common B-cell lymphomas. It is therefore appropriate to highlight the current stat
Nature – People who have received transplants for blood cancer, some more than 40 years ago, do not have high rates of potentially cancer-causing mutations.
Key Points. CNS relapse rate in HGBCL-DH-BCL2 (6.8% at 2 years) is much lower than previously reported and is associated with clinical risk factors.DZsig r
This year’s pivotal election will shape the future of US science. Rising international competition and domestic concerns are also at play.
The benefits and harms of cervical cancer screening are delicately balanced, why participation should be based on an informed choice. In the process of obtaining…
April 10, 2024, by Cancer Rose DOI: 10.1177/13634593241234481journals.sagepub.com/home/hea Authors of the article : Christina Sadolin Damhus, Post doc PhD , Centre of Research and Education in…
BCR::ABL1-negative myeloproliferative neoplasms (MPN) are clonal hematological malignancies resulting from the proliferation of myeloid cells harboring a J
Editorial: The chancellor has given the health service a boost. But huge challenges remain
Risk of diabetes and high blood pressure significantly lower in middle age in UK adults given low-sugar diets in the womb and as infants
